The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
Abstract Background People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a st...
Saved in:
Main Authors: | M. Maticic (Author), Z. Pirnat (Author), A. Leicht (Author), R. Zimmermann (Author), T. Windelinck (Author), M. Jauffret-Roustide (Author), E. Duffell (Author), T. Tammi (Author), E. Schatz (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
by: Mojca Maticic, et al.
Published: (2024) -
Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
by: Rosmawati Mohamed, et al.
Published: (2019) -
Harm reduction in Europe: a framework for civil society-led monitoring
by: Rafaela Rigoni, et al.
Published: (2021) -
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
by: Stephanie Popping, et al.
Published: (2019) -
Barriers to eliminating HIV transmission in England by 2030
by: Brooke E Nichols, et al.
Published: (2021)